NIPRO Wins FDA Clearance for ELISIO-HX Expanded HD Dialyzer
OSAKA, Japan, July 30, 2026 NIPRO CORPORATION has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
OSAKA, Japan, July 30, 2026 NIPRO CORPORATION has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...
